4D Medicine raised £3.4M in a Series A investment led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital, and private investors.
4D Medicine raised £3.4M in a Series A investment led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital, and private investors.
07/26/24, 8:13 AM
Location
nottinghamMoney raised
£3.4 million
Industry
medical device
biotechnology
health care
manufacturing
Round Type
series a
Investors
Boundary Capital, Sfc Capital, Dsw Ventures, Oshen Holdings
4D Medicine, a UK-based startup, has raised £3.4 million in Series A investment. The round was led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital, and private investors. The company, founded in 2020, has developed a resorbable biomaterial, 4Degra, to develop implants for patients recovering from surgery or injuries. The funding will enable the company to complete pre-clinical testing of its first product range and seek FDA clearance for entry into the US market.
Company Info
Location
nottingham, england, united kingdom
Additional Info
4D Medicine is a UK-based startup that focuses on developing resorbable biomaterial, 4Degra, for medical implants such as orthopaedic devices or soft tissue scaffolds. The company aims to provide safer and more effective alternatives to existing resorbable biomaterials by addressing their limitations.